BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Australian Diabetes Society - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.diabetessociety.com.au
X-WR-CALDESC:Events for Australian Diabetes Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20220402T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20221001T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Brisbane
BEGIN:STANDARD
TZOFFSETFROM:+1000
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20220402T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20221001T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Adelaide
BEGIN:STANDARD
TZOFFSETFROM:+1030
TZOFFSETTO:+0930
TZNAME:ACST
DTSTART:20220402T163000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0930
TZOFFSETTO:+1030
TZNAME:ACDT
DTSTART:20221001T163000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1030
TZOFFSETTO:+0930
TZNAME:ACST
DTSTART:20230401T163000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0930
TZOFFSETTO:+1030
TZNAME:ACDT
DTSTART:20230930T163000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1030
TZOFFSETTO:+0930
TZNAME:ACST
DTSTART:20240406T163000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0930
TZOFFSETTO:+1030
TZNAME:ACDT
DTSTART:20241005T163000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20260420T000000
DTEND;TZID=Australia/Melbourne:20260424T235959
DTSTAMP:20260528T054015
CREATED:20241213T060428Z
LAST-MODIFIED:20251003T005038Z
UID:10000079-1776643200-1777075199@www.diabetessociety.com.au
SUMMARY:21st Immunology of Diabetes Society Congress & Australian Islet Study Group Meeting 2026
DESCRIPTION:The Australian Diabetes Society (ADS) is delighted to be hosting the 21st Immunology of Diabetes Society (IDS) Congress in Brisbane\, Australia from the 20th to 24th April 2026. \nThe IDS Congress 2026 will be held in conjunction with the Australian Islet Study Group (AISG) Meeting. The congress will convene a high-quality program covering the most recent advances in type 1 diabetes pathogenesis\, underlying mechanisms and therapeutic advances. Our goal is to create a congress that reflects the diversity of the type 1 diabetes research field. There have been significant advancements in type 1 diabetes research that are being translated to clinical practice\, such that the possibility of delaying or even preventing this disease is becoming a reality. The Congress will serve as a platform for researchers and clinicians from across the globe to pursue this goal\, fostering networking\, discussion and collaboration. We thank members on the organising committees in preparing for what will be an exciting program. Brisbane is a vibrant\, subtropical city offering a blend of natural beauty\, cultural attractions and culinary delights. Extend your stay and discover our iconic beaches\, unique Australian wildlife\, coral reefs and rainforests. \nFor more details about the event\, including abstract submissions and registration information\, please visit the official IDS Congress 2026 website. See the Program at a Glance. \nThe ADS looks forward to you joining us in Brisbane in 2026 for what promises to be an exceptional event.
URL:https://www.diabetessociety.com.au/event/21st-immunology-of-diabetes-society-congress-australian-islet-study-group-meeting-2026/
LOCATION:Brisbane Convention & Exhibition Centre\, Glenelg St\, South Brisbane\, QLD\, 4101\, Australia
CATEGORIES:ADS Educational Events,General,National Meetings
ATTACH;FMTTYPE=image/jpeg:https://www.diabetessociety.com.au/wp-content/uploads/2024/12/IDS2026_logo.jpg
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20260221T080000
DTEND;TZID=Australia/Melbourne:20260221T181500
DTSTAMP:20260528T054015
CREATED:20251211T013518Z
LAST-MODIFIED:20251211T013545Z
UID:10000096-1771660800-1771697700@www.diabetessociety.com.au
SUMMARY:ADS Practical Skills Course 2026
DESCRIPTION:The Australian Diabetes Society is running its annual Practical Skills Course for First Year Trainees in Adult Endocrinology over two days with the first day held on Saturday 21st February 2026 from 8.00am to 6.15pm (AEDT) at the Crowne Plaza Hotel in Melbourne. The second day will be held as an online virtual event on Saturday 23rd May 2026 from 9.30am to 5.15pm (AEST). \nThe two-day course will focus on the hands-on practical skills required to effectively care for people with diabetes in inpatient and ambulatory clinical settings. It will be run by senior endocrinologists and other diabetes health professionals. \nThe program will consist of lecture sessions and small group workshops on topics including:\n1. Key landmark trials in CVRM\n2. Prescribing medications for type 2 diabetes\n3. Measuring glucose levels\n4. Insulin and other injectable therapies\n5. Managing Inpatient glycaemia\, including peri-operative management\n6. Managing the diabetic foot (including ulcer management and footwear)\n7. Programming insulin pumps (with hands-on experience)\n8. Diabetes technology downloads (insulin pump/CGM)\n9. Case Studies in Type 1 Diabetes & Type 2 Diabetes\n10. Diabetes eye examination & retinopathy \nSupervisors are encouraged to advise incoming first year trainees of this course. \nRegistration Fee: $176 (inc $16 GST) for both days. Full payment is required at time of completing the online registration. Please note\, no refunds will be issued if cancelled after 16th February 2026. \nPlease note the following registration conditions:\n\nRegistration to the course is only open for First Year Advanced Trainees in Adult Endocrinology \nTrainees must be undertaken the RACP Physicians Training Program in 2026\nIt is important to note that trainees are required to attend both days to receive their certificate of attendance\nEarly registration is recommended as places are strictly limited\nRegistration closes on Monday 2nd February 2026\n\nDownload the 2026 ADS Practical Skills Course Flyer  \nDownload the 2026 ADS PSC Preliminary Program Day 1 (Saturday 21st February 2026) \n\nRegister Online\n \nFor any further details regarding the course\, please contact Ms Linda Valenzisi via email to linda@diabetessociety.com.au or visit the ADS website at Advanced Trainees (diabetessociety.com.au) \nThis course is financially supported under the National Diabetes Services Scheme (NDSS). The National Diabetes Services Scheme is an initiative of the Australian Government and is administered by Diabetes Australia. The ADS also gratefully acknowledges the contribution and support from Abbott Australia\, AMSL diabetes\, Insulet Australia\, Medtronic Diabetes Australia and Ypsomed Australia.
URL:https://www.diabetessociety.com.au/event/ads-practical-skills-course-2026/
LOCATION:Crowne Plaza Hotel Melbourne\, 1-5 Spencer St\, Melbourne\, VIC\, 3008\, Australia
CATEGORIES:ADS Education Courses for Advanced Trainees in Adult Endocrinology,ADS Educational Events,National Meetings
ATTACH;FMTTYPE=image/jpeg:https://www.diabetessociety.com.au/wp-content/uploads/2025/12/PSC-Course-Flyer-3rd-Dec-small-e1765416841991.jpg
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20250820T080000
DTEND;TZID=Australia/Melbourne:20250822T170000
DTSTAMP:20260528T054015
CREATED:20250416T044343Z
LAST-MODIFIED:20250416T052658Z
UID:10000087-1755676800-1755882000@www.diabetessociety.com.au
SUMMARY:Australasian Diabetes Congress 2025
DESCRIPTION:The Australian Diabetes Society (ADS) and the Australian Diabetes Educators Association (ADEA) reaffirm their strong partnership as leaders in diabetes education\, management and research. The exciting and innovative program will bring together national and international experts to promote the exchange of the latest clinical practices and cutting-edge research in diabetes. State-of-the-Art lectures\, free communication sessions and clinical and scientific educational symposia\, will all be appreciated by the 2025 attendees #25ADC \nPlease visit the official Australasian Diabetes Congress for further information including registration.
URL:https://www.diabetessociety.com.au/event/australasian-diabetes-congress-2025/
CATEGORIES:ADS Educational Events,National Meetings
ATTACH;FMTTYPE=image/jpeg:https://www.diabetessociety.com.au/wp-content/uploads/2023/10/ADC-LOGO-1.jpg
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Brisbane:20250819T120000
DTEND;TZID=Australia/Brisbane:20250819T180000
DTSTAMP:20260528T054015
CREATED:20250131T051047Z
LAST-MODIFIED:20250814T032654Z
UID:10000080-1755604800-1755626400@www.diabetessociety.com.au
SUMMARY:ADS Early Career Network Workshop 2025
DESCRIPTION:We invite all early career ADS members to be part of the ADS Early Career Network (ECN)\, an ADS initiative to support clinicians and scientists with an interest in diabetes. The ADS ECN Subcommittee has developed a structure focused on four key pillars: research\, education\, professional development and social networking. By working collaboratively with senior ADS members\, we hope to build a community of peer-to-peer support and to help our early career members increase their visibility and maximise their skills and impact. \nThe ADS ECN Subcommittee is excited to offer an exclusive half-day workshop to a limited number of ADS early career members attending #25ADC on Tuesday\, 19th August 2025. This workshop\, which is designed and led by early career members with the support of senior facilitators\, will focus on our four key pillars and offers a unique opportunity to network and shape the future of the ECN. The workshop will be held at the Sofitel Gold Coast Broadbeach and you are required to attend the Australasian Diabetes Congress to register for the ADS ECN Workshop. Registration fee is $88 (includes $8 GST). For any further information\, please contact the ADS Secretariat via email: admin@diabetessociety.com.au \nClick here to view the event flyer.\nClick here to view the program.\nClick here to register! \nThe ADS gratefully acknowledges the support from Sanofi for the workshops and the support from AstraZeneca for the networking drinks.\n     \n\n  \nExclusive Deal for ADS ECN Workshop 2025 Delegates \nRegister for the ADS ECN Workshop 2025 and receive special pricing for Australasian Diabetes Advancements and Technologies Summit (ADATS) 2025 half-day registration! The ADATS program includes some amazing national and international leaders in diabetes technology. Take advantage of this opportunity to gain valuable insights and expand your professional network in the field of diabetes. ADS ECN Workshop 2025 delegates can register for ADATS’ half-day session for just $55 by clicking here. If you have any questions or require further assistance regarding ADATS 2025\, please send an email to: admin@nadc.net.au
URL:https://www.diabetessociety.com.au/event/ads-ecn-workshop-2025/
LOCATION:Sofitel Gold Coast Broadbeach\, 81 Surf Parade\, Broadbeach\, QLD\, 4218\, Australia
CATEGORIES:ADS Educational Events,General,National Meetings
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2024/03/ADS-ECN-Logo.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20250818T080000
DTEND;TZID=Australia/Melbourne:20250818T173000
DTSTAMP:20260528T054015
CREATED:20250524T031930Z
LAST-MODIFIED:20250524T093849Z
UID:10000088-1755504000-1755538200@www.diabetessociety.com.au
SUMMARY:ADS Diabetes Technology Workshop 2025
DESCRIPTION:The Australian Diabetes Society is proud to host the ADS Diabetes Technology Workshop which will be held over 1 day on Monday 18 August 2025 in the Gold Coast at the Gold Coast Convention & Exhibition Centre\, QLD. \nThe workshop is primarily open to clinicians (endocrinologists or consultant physicians) who manage people living with type 1 diabetes. The aim of the workshop is to provide structured practical training about insulin pumps and other technologies used in diabetes self-management. This workshop contains new content to reflect the recent developments in insulin pump therapy and CGM technologies. The program will consist of a series of small group workshops and also a number of lecture sessions. This will allow for hands-on skills acquisition. Each workshop will be supported by structured written materials. \nTopics to be covered include:  \n\nFamiliarisation and understanding pump settings;\nContinuous glucose monitoring;\nDietary management with AID systems;\nAutomated Insulin Delivery systems;\nInterpreting technology downloads;\nExercise and pumps;\nNew and emerging developments in insulin pump therapy;\nClinical situations including inpatient management\, perioperative situations\, pregnancy.\n\nDownload the 2025 ADS Diabetes Technology Workshop Flyer\nDownload the 2025 ADS Diabetes Technology Workshop Preliminary Program  \nOptional Pre-Workshop:\nThere will be an option for delegates to attend a pre-workshop on ‘Introduction to Diabetes Technology’ that will be held on Monday 18 August 2025 from 8:00am to 8:30am. This pre-workshop is recommended for those clinicians who have minimal experience with diabetes technology especially in using insulin pumps. Spaces are limited for the pre-workshop; you will need to advise during the registration process if you wish to attend. \nNetworking Social Function:\nThere will be a networking social function on Monday 18 August 2025 from 5:30pm to 6:30pm. \nRegistration Fees:\n \nRegistration fee includes the optional pre-workshop\, attendance to all lecturettes/workshops\, networking social function\, program handbook and all the relevant workshop resources/handouts. Attendees will be given the option to apply and trial a CGM sensor device which must be done during registration. \nADS Member Registration Fee is $286 (includes $26 GST) / Non-Member Registration Fee is $330 (includes $30 GST). \n\nRegister Online\n \nPlease note the following conditions: \n\nEarly registration is recommended as places are strictly limited. A waitlist will be in-place once all available registrations have been exhausted.\nDelegates travelling from interstate will need to organise their own travel arrangements (air travel and accommodation) to attend the workshop in Melbourne.\nIf you are currently not a member of the Australian Diabetes Society and wish to join; to apply for ADS Membership\, please go to the following link ADS Membership – Australian Diabetes Society via the ADS website to submit your Membership Application Form.\nCancellation fees do apply. Please provide the ADS Secretariat notice by no later than Monday 4 August 2025 if you are unable to attend the workshop. After this date\, the registration fee will be non-refundable.\nThis workshop is not open to Endocrinology Advanced Trainees\, CDE’s\, Nurse Practitioners\n\nFor any further workshop details\, please contact Ms Linda Valenzisi via email to linda@diabetessociety.com.au\n \nRegistration closes on Friday 18 July 2025.\n \nThis workshop is financially supported under the National Diabetes Services Scheme (NDSS). The NDSS is an initiative of the Australian Government and is administered by Diabetes Australia. The Australian Diabetes Society gratefully acknowledges the generous support also provided from Abbott Australasia\, Australasian Medical & Scientific Ltd\, Insulet Australia\, Medtronic Australasia and Ypsomed Australia.\n    
URL:https://www.diabetessociety.com.au/event/ads-diabetes-technology-workshop-2025/
LOCATION:Gold Coast Convention & Exhibition Centre\, 2684-2690 Gold Coast Hwy\, Broadbeach\, 4218\, Australia
CATEGORIES:ADS Educational Events,National Meetings
ATTACH;FMTTYPE=image/jpeg:https://www.diabetessociety.com.au/wp-content/uploads/2025/05/Pump-Technology-flyer-28th-April-small-e1748056725689.jpg
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20250705T090000
DTEND;TZID=Australia/Melbourne:20250705T170000
DTSTAMP:20260528T054015
CREATED:20250416T041509Z
LAST-MODIFIED:20250416T043940Z
UID:10000086-1751706000-1751734800@www.diabetessociety.com.au
SUMMARY:23rd ADS John R Turtle Diabetes Clinical Skills Training Course
DESCRIPTION:The ADS John R Turtle Diabetes Clinical Skills Training Course for Advanced Trainees in Adult Endocrinology is designed to be practical and interactive. It will be run by experienced diabetes clinicians from across Australia and will focus on everyday clinical skills required in the treatment of diabetes by endocrinology trainees. The course is supported by the Advanced Training Committee (ATC) in Endocrinology from the Royal Australasian College of Physicians (RACP). \nThis course is in honour of the esteemed and founding life member of the Australian Diabetes Society; late Professor Emeritus John R Turtle AO. \nThe 23rd ADS John R Turtle Diabetes Clinical Skills Training Course will be held as an online virtual event on Saturday 5th July 2025 from 9.00am to 5.00pm (AEST).  \nThis year\, we are offering the following topics to all: \n\nDiabetes Technology; Interpreting pump and CGM data downloads\nManaging Type 1 and Type 2 diabetes and Pregnancy\nExercise and Type 1 Diabetes\nType 1 Diabetes Prediction and Prevention \nManaging Lipids in People with Diabetes\n\nAttendance Eligibility:\n\nThis course is only open to Advanced Trainees currently enrolled with the Royal Australian College of Physicians (RACP) as a 1st\, 2nd or 3rd year trainee in Adult Endocrinology. It is not open for Allied Health Professionals\, Consultant Physicians or General Practitioners.\n\n\nRegister:\n\nPlease click HERE to register online. Registrations close on Friday 20th June\, 2025.\n\nRegister Online\n\n\nDownloads:\n\n\n\nPlease download the 2025 ADS JRT Course Preliminary Program\nPlease download the 2025 ADS JRT Course Flyer\n\nCancellation Policy:\nPlease provide the ADS Secretariat notice by no later than Friday 27th June\, 2025 if you are unable to attend the course. \nTo apply for ADS Membership\, please go to the following link https://diabetessociety.com.au/membership-apply-online.asp via the ADS website to submit your Membership Application Form. \n\n\n\n\nFor any further details regarding the course\, please contact Ms Linda Valenzisi via email to linda@diabetessociety.com.au or visit the ADS website at Advanced Trainees (diabetessociety.com.au) \nThis course is financially supported under the National Diabetes Services Scheme (NDSS). The National Diabetes Services Scheme is an initiative of the Australian Government and is administered by Diabetes Australia.  \n \nThe ADS also gratefully acknowledges the contribution and support from Abbott Australasia. \n\n 
URL:https://www.diabetessociety.com.au/event/23rd-ads-john-r-turtle-diabetes-clinical-skills-training-course/
CATEGORIES:ADS Educational Events,Virtual Event
ATTACH;FMTTYPE=image/jpeg:https://www.diabetessociety.com.au/wp-content/uploads/2025/04/2025-ADS-JRT-Course-Flyer_Final-web-image-scaled-e1744777427276.jpg
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20250625T000000
DTEND;TZID=Australia/Melbourne:20250625T235959
DTSTAMP:20260528T054015
CREATED:20250620T050900Z
LAST-MODIFIED:20250623T231802Z
UID:10000089-1750809600-1750895999@www.diabetessociety.com.au
SUMMARY:Highlights from American Diabetes Association (ADA) 85th Scientific Sessions
DESCRIPTION:Join us as we bring you the latest highlights from the American Diabetes Association (ADA) 85th Scientific Sessions in Chicago\, IL\, USA\, taking place 20-23 June 2025! \nThe sessions that we will be focusing on: \n\nDiabetes and Peripheral Artery Disease—Evolving Role of GLP-1 RA and New Insights from the STRIDE Trial\nEmerging Non-Peptide\, Small Molecule GLP-1 Receptor Agonists—Can They Become Players?\nUnanticipated Hot Topics in GLP-1 +/- GIP RA\n\nWe will providing a highlight videos at the end of the conference. Click here to watch the highlight videos as they become available. \nFor any enquiries\, please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\nThe ADS gratefully acknowledges the support from Lilly and Novo Nordisk.
URL:https://www.diabetessociety.com.au/event/highlights-from-ada-2025/
CATEGORIES:ADS Educational Events,International Meetings,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2025/06/ADS-Event-Highlights_ADA-Jun-2025.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20250501T000000
DTEND;TZID=Australia/Melbourne:20250502T235959
DTSTAMP:20260528T054015
CREATED:20241211T032649Z
LAST-MODIFIED:20250430T005056Z
UID:10000078-1746057600-1746230399@www.diabetessociety.com.au
SUMMARY:Australian Islet Study Group Meeting 2025
DESCRIPTION:The Australian Islet Study Group (AISG) Meeting is the premier meeting for researchers interested in all aspects of islet and beta cell function; including secretion pathway mechanisms\, islet structure and function\, morphology\, in vitro and in vivo models\, omics and big data considerations. We invite you to attend this exciting annual meeting discussing islet biology as it relates to clinical situations including diabetes and challenges in islet transplantation. The AISG Meeting 2025 will take place on Thursday\, 1st & Friday\, 2nd May 2025 at the University of Adelaide (AHMS Building\, G033 Joe Verco Lecture Theatre 2) in Adelaide\, SA. \nClick here for the program.\nClick here to register for the event. \nFull registration: A$190.00 (GST included)\nStudent registration: A$90.00 (GST included) \n\nSpeakers \n\n\n\n\n\n\n\n\nKeynote Speaker\nProfessor James Johnson\nJim Johnson is a Professor in the Department of Cellular & Physiological Sciences and the Department of Surgery at the University of British Columbia (UBC) in Canada. He is Associate Director of Vancouver Coastal Health Research Institute at UBC. A leader in the fundamental biology of pancreatic islets\, insulin action\, diabetes and their connections to co-morbidities\, Professor Johnson is the author of >179 peer-reviewed articles since starting in 2000. His laboratory at the UBC Life Sciences Institute focuses on understanding the causes of type 1 and type 2 diabetes at a molecular level. Professor Johnson and his team study the role of the insulin-secreting pancreatic beta-cell in type 1 diabetes\, type 2 diabetes\, and other rare forms of diabetes using state-of-the-art techniques including molecular imaging\, molecular biology and in vivo studies. His group also has research programs that investigate the role of insulin in insulin resistance\, obesity\, cancer\, and accelerated aging. He is also Editor-in-Chief of the journal Islets and co-founder of the Institute for Personalized Therapeutic Nutrition.\n\n\n\n\n\n\n\n\n\n \n\nProgram \nClick to view the program. \n\n\n\nThe ADS gratefully acknowledges the support from Abbott\, Lilly\, Sanofi\, Beta Cell Technologies\, Breakthrough T1D and Boehringer Ingelheim for this educational event.
URL:https://www.diabetessociety.com.au/event/aisg-meeting-2025/
LOCATION:University of Adelaide\, Adelaide\, SA\, 5005\, Australia
CATEGORIES:ADS Educational Events,General,National Meetings
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2024/12/AISG-2025-Image.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20250327T190000
DTEND;TZID=Australia/Sydney:20250327T200000
DTSTAMP:20260528T054015
CREATED:20250313T044356Z
LAST-MODIFIED:20250314T022555Z
UID:10000084-1743102000-1743105600@www.diabetessociety.com.au
SUMMARY:Updates on the Use of SGLT2i in Type 2 Diabetes Complications Management
DESCRIPTION:Join us on Thursday\, 27 March 2025 from 7:00 pm to 8:00 pm (AEDT) as we deliver an update on the role of SGLT2i in the management of type 2 diabetes and its complications. We will be reviewing the latest clinical evidence that has informed recent changes to reimbursement rules. \nThis webinar will cover: \n\nLatest clinical evidence for SGLT2i and type 2 diabetes\nThe use of SGLT2i in combination with other medications\nClinical considerations\nUpdate on adverse events and their management\n\nSpeakers\n \nClick here to view the event flyer.\nClick here to register for the webinar. \nFor any further information\, please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\n    The ADS gratefully acknowledges the support from AstraZeneca and Medi-Spec Solutions for this educational diabetes webinar.
URL:https://www.diabetessociety.com.au/event/updates-on-the-use-of-sglt2i-in-type-2-diabetes-complications-management/
CATEGORIES:ADS Educational Events,General,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2025/03/ADS-Webinar_27-Mar-2025.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20241205T190000
DTEND;TZID=Australia/Melbourne:20241205T200000
DTSTAMP:20260528T054015
CREATED:20241113T045653Z
LAST-MODIFIED:20241119T020054Z
UID:10000076-1733425200-1733428800@www.diabetessociety.com.au
SUMMARY:The Role of GLP-1 Based Therapies in Liver Fibrosis and MASH
DESCRIPTION:Join us on Thursday\, 5 December 2024 from 7:00 pm to 8:00 pm (AEDT) as we discuss the latest trials on the management of MASH in people with and without diabetes. We’ll focus on the Australian clinical context\, considering GESA’s recent position statement on MAFLD screening and diagnosis as well as ADS’ provision statement on managing the condition. \nThis webinar will cover: \n\n\nEpidemiology and diagnosis of MAFLD and MASH\nKey clinical studies and outcomes\nAustralian position statements/guidelines\nImplications for the clinical management of MASH\n\n\nSpeakers\n \nClick here to view the event flyer.\nClick here to register for the webinar. \nRegistration is free to attend. \nFor any further information please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\nThe ADS gratefully acknowledges the support from Novo Nordisk for this educational diabetes webinar.
URL:https://www.diabetessociety.com.au/event/glp1-therapies-mafld-mash/
CATEGORIES:ADS Educational Events,General,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2024/11/ADS-GESA-Webinar_5-Dec-2024-3.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20241012T000000
DTEND;TZID=Australia/Melbourne:20241013T235959
DTSTAMP:20260528T054015
CREATED:20240905T000031Z
LAST-MODIFIED:20240930T081611Z
UID:10000073-1728691200-1728863999@www.diabetessociety.com.au
SUMMARY:ADS Diabetes Technology Workshop 2024
DESCRIPTION:The Australian Diabetes Society is proud to host the ADS Diabetes Technology Workshop which will be held over 1.5 days on Saturday 12 & Sunday 13 October 2024 in Melbourne at the Crowne Plaza Hotel. \nThe workshop is primarily open to clinicians (endocrinologists or consultant physicians) who manage people living with type 1 diabetes. The aim of the workshop is to provide structured practical training about insulin pumps and other technologies used in diabetes self-management. This workshop contains new content to reflect the recent developments in insulin pump therapy and CGM technologies. The program will consist of a series of small group workshops\, with between 6-8 participants per group. This will allow for hands-on skills acquisition. Each workshop will be supported by structured written materials. \nTopics to be covered include: \nFamiliarisation and understanding pump settings\, Continuous glucose monitoring\, Dietary management with AID systems\, Automated Insulin Delivery Systems\, Interpreting technology downloads\, Exercise and pumps\, New and emerging developments in insulin pump therapy.\n \n\nYou can download the 2024 ADS Diabetes Technology Workshop Flyer\nYou can download the 2024 ADS Diabetes Technology Workshop Preliminary Program_Day 1 and Day 2 (please check the program for timings AEDT on both days)\n\nOptional Pre-Workshop:\nThere will be an option for delegates to attend a pre-workshop on ‘Introduction to Diabetes Technology’ that will be held on Saturday 12 October from 8:00am to 9:00am. This pre-workshop is recommended for those clinicians who have minimal experience with diabetes technology especially in using insulin pumps. Spaces are very limited for the pre-workshop; you will need to advise during the registration process if you wish to attend. \nNetworking Social Function:\nThere will be a networking social function on Saturday 12 October 2024 from 5:40pm to 7:30pm. \nRegistration Fees:\n \nRegistration fee includes attendance to both Day 1 and Day 2\, the optional pre-workshop\, networking social function on Saturday 12 October\, program handbook and all the relevant workshop resources/handouts. Attendees will be given the option to apply and trial a CGM device. \nADS Member Registration Fee is $330 (includes $30 GST) / Non-Member Registration Fee is $429 (includes $39 GST). \n\nRegister Online\n \nPlease note the following conditions: \n\nEarly registration is recommended as places are strictly limited. A waitlist will be in-place once all available registrations have been exhausted.\nDelegates travelling from interstate will need to organise their own travel arrangements (air travel and accommodation) to attend the workshop in Melbourne.\nIf you are currently not a member of the Australian Diabetes Society and wish to join; to apply for ADS Membership\, please go to the following link ADS Membership – Australian Diabetes Society via the ADS website to submit your Membership Application Form.\nCancellation fees do apply. Please provide the ADS Secretariat notice by no later than Monday 7 October 2024 if you are unable to attend the workshop. After this date\, the registration fee will be non-refundable.\nThis workshop is not open to Endocrinology Advanced Trainees\, CDE’s\, Nurse Practitioners\n\nFor any further workshop details\, please contact Ms Linda Valenzisi via email to linda@diabetessociety.com.au\n \nRegistration closes on Wednesday 2 October 2024.\n \nThis workshop is financially supported under the National Diabetes Services Scheme (NDSS). The NDSS is an initiative of the Australian Government and is administered by Diabetes Australia. The Australian Diabetes Society gratefully acknowledges the generous support also provided from Abbott Australasia\, Australasian Medical & Scientific Ltd\, Insulet Australia\, Medtronic Australasia and Ypsomed Australia.\n    
URL:https://www.diabetessociety.com.au/event/10901/
LOCATION:Crowne Plaza Hotel Melbourne\, 1-5 Spencer St\, Melbourne\, VIC\, 3008\, Australia
CATEGORIES:ADS Educational Events,National Meetings
ATTACH;FMTTYPE=image/jpeg:https://www.diabetessociety.com.au/wp-content/uploads/2024/09/ADS-Diabetes-Technology-Workshop-2024-_-Flyer-website-image-e1725579533706.jpg
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240821T000000
DTEND;TZID=Australia/Melbourne:20240823T235959
DTSTAMP:20260528T054015
CREATED:20230320T042426Z
LAST-MODIFIED:20240508T123708Z
UID:10000027-1724198400-1724457599@www.diabetessociety.com.au
SUMMARY:ADS/ADEA Australasian Diabetes Congress (ADC)
DESCRIPTION:We are delighted to host the Australasian Diabetes Congress at the Perth Convention and Exhibition Centre\, August 21 – 23\, 2024. The content will once again be exceptional. The program organising committees of both societies have collaboratively developed an integrated program that will cover the latest breakthroughs in research\, education and clinical care in diabetes. \nWe have engaged outstanding speakers with whom you will be able to network to exchange opinions and discuss how to best care for the person living with diabetes. \nWe are excited to provide you with opportunities to see old colleagues\, meet new ones and connect again with our industry partners in the exhibition hall. This year’s Congress will be an in-person only event with no virtual attendance option. \nWe look forward to seeing you in Perth in 2024. \nSof and Susan\, \nADS & ADEA CEOs
URL:https://www.diabetessociety.com.au/event/ads-adea-australasian-diabetes-congress-adc-2/
LOCATION:Perth Convention and Exhibition Centre\, 21 Mounts Bay Road\, Perth\, WA\, 6000\, Australia
CATEGORIES:ADS Educational Events,General,National Meetings
ATTACH;FMTTYPE=image/jpeg:https://www.diabetessociety.com.au/wp-content/uploads/2023/02/ADC-LOGO-2.jpg
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240820T130000
DTEND;TZID=Australia/Melbourne:20240820T190000
DTSTAMP:20260528T054015
CREATED:20240326T074644Z
LAST-MODIFIED:20240819T015900Z
UID:10000059-1724158800-1724180400@www.diabetessociety.com.au
SUMMARY:ADS Early Career Network Workshop 2024
DESCRIPTION:We invite all early career ADS members to be part of the ADS Early Career Network (ECN)\, an ADS initiative to support clinicians and scientists with an interest in diabetes. The ADS ECN Subcommittee has developed a structure focused on four key pillars: research\, education\, professional development and social networking. By working collaboratively with senior ADS members\, we hope to build a community of peer-to-peer support and to help our early career members increase their visibility and maximise their skills and impact. \nThe ADS ECN Subcommittee is excited to offer an exclusive half-day workshop to a limited number of ADS early career members attending #24ADC on Tuesday\, 20th August 2024. We are thrilled the workshop is co-supported by Rio Tinto Children’s Diabetes Centre (JDRF Global Centre Excellence). The workshop\, which is designed and led by early career members with the support of senior facilitators\, will focus on our four key pillars and offers a unique opportunity to network and shape the future of the ECN. The Workshop will be held at the Perth Convention and Exhibition Centre (Meeting Rooms 7 & 8 on Level 2) and you are required to attend the Australasian Diabetes Congress to register for the ADS ECN Workshop. Registration fee is $55 (includes $5 GST). For any further information please contact the ADS Secretariat via email to admin@diabetessociety.com.au \nClick here to view the event flyer.\nClick here to view the program.\nClick here to register! \nThe sundowner event is proudly supported by the Rio Tinto Children’s Diabetes Centre (JDRF Global Centre of Excellence). \n \n\n  \nExclusive Deal for ADS ECN Workshop 2024 Delegates \nRegister for the ADS ECN Workshop 2024 and receive special pricing for Australasian Diabetes Advancements and Technologies Summit (ADATS) 2024 half-day registration! ADATS 2024 will also be hosted at the Perth Convention and Exhibition Centre\, conveniently located alongside the ADS ECN workshops\, making it easily accessible. The ADATS program includes some amazing national and international leaders in diabetes technology. Take advantage of this opportunity to gain valuable insights and expand your professional network in the field of diabetes. ADS ECN Workshop 2024 delegates can register for ADATS’ half-day session for just $50 by clicking here. If you have any questions or require further assistance regarding ADATS 2024\, please send an email to: admin@nadc.net.au
URL:https://www.diabetessociety.com.au/event/ads-ecn-workshop-2024/
LOCATION:Perth Convention and Exhibition Centre\, 21 Mounts Bay Road\, Perth\, WA\, 6000\, Australia
CATEGORIES:ADS Educational Events,General,National Meetings
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2024/03/ADS-ECN-Logo.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240725T190000
DTEND;TZID=Australia/Melbourne:20240725T200000
DTSTAMP:20260528T054015
CREATED:20240613T081310Z
LAST-MODIFIED:20240613T081310Z
UID:10000065-1721934000-1721937600@www.diabetessociety.com.au
SUMMARY:Diabetes and Effects on the Kidney and Heart – The Benefits of SGLT2i
DESCRIPTION:Join us on Thursday\, 25 July 2024 from 7:00 pm to 8:00 pm (AEST) as we discuss the following in relation to the benefits of SGLT2 inhibitors in diabetes management: \n\nRole of glycaemic control\nImpact of glucose lowering on renal and cardiac function\nWhere SGLT2i fit in and change the paradigm\nNavigating the new PBAC recommendations on SGLT2i and GLP-1a\n\nSpeakers\n \nClick here to view the event flyer.\nClick here to register for the webinar. \nFor any further information please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\n    The ADS gratefully acknowledges the support from Boehringer Ingelheim and Lilly for this educational diabetes webinar.
URL:https://www.diabetessociety.com.au/event/diabetes-and-effects-on-the-kidney-and-heart-the-benefits-of-sglt2i/
CATEGORIES:ADS Educational Events,General,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2024/06/Banner_ADS-Webinar_25-Jul-2024.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240621T000000
DTEND;TZID=Australia/Melbourne:20240624T235959
DTSTAMP:20260528T054015
CREATED:20240618T033033Z
LAST-MODIFIED:20240618T033158Z
UID:10000066-1718928000-1719273599@www.diabetessociety.com.au
SUMMARY:Highlights from American Diabetes Association (ADA) 84th Scientific Sessions
DESCRIPTION:21-24 June 2024\nJoin us as we bring you the latest highlights from the American Diabetes Association (ADA) 84th Scientific Sessions in Orlando\, FL\, USA\, taking place 21-24 June 2024! \nThe sessions that we will be focusing on: \n\nSURMOUNT-OSA Trial Results and Potential Role of Tirzepatide in Treating Obesity-Related Obstructive Sleep Apnea\nSELECT Trial—New Looks at Glycemia\, Inflammation\, and Heart Failure\nTHE STEP-HFpEF and STEP-HFpEF-DM Trials—Targeting Obesity to Treat Heart Failure\nThe First Dedicated Kidney Outcome Trial with a GLP-1 Receptor Agonist—Once-Weekly Semaglutide and the FLOW Trial Results\n\nWe will providing a highlight video at the end of each day at the conference. Click here to watch the daily highlight videos as they become available. \nFor any enquiries\, please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\nThe ADS gratefully acknowledges the support from AstraZeneca\, Lilly and Novo Nordisk.
URL:https://www.diabetessociety.com.au/event/highlights-from-ada-2024/
CATEGORIES:ADS Educational Events,International Meetings,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2024/06/ADS-Event-Highlights_ADA-Jun-2024.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240527T190000
DTEND;TZID=Australia/Melbourne:20240527T200000
DTSTAMP:20260528T054015
CREATED:20240426T055300Z
LAST-MODIFIED:20240503T055935Z
UID:10000061-1716836400-1716840000@www.diabetessociety.com.au
SUMMARY:Updates from European Renal Association (ERA) Congress 2024 – Outcomes and Clinical Implications of GLP-1 RA in T2DM and CKD
DESCRIPTION:Live Panel Discussion\nThe use of GLP-1 agonists are revolutionising the care of type 2 diabetes and chronic kidney disease. Join us on Monday\, 27 May 2024 from 7:00 pm to 8:00 pm (AEST) as our panel of experts discuss the effects of GLP-1 agonists on renal outcomes. \nWe will be reviewing study results presented at the ERA Congress 2024 and their implications for clinical practice in Australia. \n\nExpert Panel\n \nClick here to view the event flyer.\nClick here to register for the webinar. \nRegistration is free to attend. \nFor any further information please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\n\nThe ADS gratefully acknowledges the support from Novo Nordisk. This is an independent educational event and Novo Nordisk does not have an influence on the program\, speakers or presentations.
URL:https://www.diabetessociety.com.au/event/era-congress-2024-updates/2024-05-27/
CATEGORIES:ADS Educational Events,General,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2024/04/Webinar-27-May-2024.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240515T000000
DTEND;TZID=Australia/Melbourne:20240516T235959
DTSTAMP:20260528T054015
CREATED:20240123T011745Z
LAST-MODIFIED:20240509T062453Z
UID:10000057-1715731200-1715903999@www.diabetessociety.com.au
SUMMARY:Australian Islet Study Group Meeting 2024
DESCRIPTION:The Australian Islet Study Group (AISG) Meeting is the premier meeting for researchers interested in all aspects of islet and beta cell function; including secretion pathway mechanisms\, islet structure and function\, morphology\, in vitro and in vivo models\, omics and big data considerations. We invite you to attend this exciting annual meeting discussing islet biology as it relates to clinical situations including diabetes and challenges in islet transplantation. The AISG Meeting 2024 will take place on Wednesday\, 15th & Thursday\, 16th May 2024 at The Westmead Institute for Medical Research in Westmead\, NSW. \nClick here for the program.\nClick here to register for the event. \nFull registration: A$190.00 (GST included)\nStudent registration: A$90.00 (GST included) \n\nSpeakers \n\n\n\n\n\n\n\n\nKeynote Speaker\nProfessor Lori Sussel\nLori Sussel is the Research Director of the Barbara Davis Diabetes Center (BDC) and Director of the NIDDK-funded University of Colorado Diabetes Research Center. She received her graduate degree from Columbia University Medical School and pursued a postdoctoral fellowship at the University of California\, San Francisco. Her research program involves two major areas of study. One aspect of her research is to understand the biology underlying pancreatic islet cell development and function. These studies have contributed to the ability to grow human islet cells in a dish for cell replacement therapy in type 1 diabetes (T1D). The second aspect of her research is to understand why the immune system targets the insulin producing beta cells within the pancreas with hopes that this knowledge will help prevent disease initiation or protect the beta cells after disease onset. As BDC Research Director\, Professor Sussel has also established an internationally recognised interdisciplinary research division focusing on all aspects of T1D research and discovery.\n\n\n\n\n\n\n\n\n\n \n\nProgram\n \nClick to view the program. \n\n   The ADS gratefully acknowledges the support from Lilly and Sanofi for this educational event.
URL:https://www.diabetessociety.com.au/event/aisg-meeting-2024/
LOCATION:The Westmead Institute for Medical Research\, 176 Hawkesbury Road\, Westmead\, NSW\, 2145\, Australia
CATEGORIES:ADS Educational Events,General,National Meetings
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2024/01/AISG-2024-Image-e1734915387588.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240217T080000
DTEND;TZID=Australia/Melbourne:20240217T180000
DTSTAMP:20260528T054015
CREATED:20231115T073313Z
LAST-MODIFIED:20231116T060925Z
UID:10000053-1708156800-1708192800@www.diabetessociety.com.au
SUMMARY:ADS Practical Skills Course 2024
DESCRIPTION:The Australian Diabetes Society is running its annual Practical Skills Course for First Year Trainees in Adult Endocrinology over two days with the first day held on Saturday 17th February 2024 from 8.00am to 6.15pm (AEDT) at the Crowne Plaza Hotel in Melbourne. The second day will be held as an online virtual event on Saturday 15th June 2024 from 9.30am to 5.15pm (AEST). \nThe two-day course will focus on the hands-on practical skills required to effectively care for people with diabetes in inpatient and ambulatory clinical settings. It will be run by senior endocrinologists and other diabetes health professionals. \nThe program will consist of 1-hour lecture sessions and 1.25-2hours small group workshops on topics including:\n1. Discussing key landmark trials in CVRM\n2. Prescribing medications for type 2 diabetes\n3. Measuring glucose levels\n4. Insulin and other injectable therapies\n5. Managing Inpatient glycaemia\, including peri-operative management\n6. Managing the diabetic foot (including ulcer management and footwear)\n7. Programming insulin pumps (with hands-on experience)\n8. Diabetes technology downloads (insulin pump/CGM)\n9. Case Studies in Type 1 Diabetes & Type 2 Diabetes\n10. Diabetes eye examination & retinopathy \nSupervisors are encouraged to advise incoming first year trainees of this course. \nRegistration Fee: $99 (inc $9GST) for both days. Full payment is required at time of completing the online registration. Please note\, no refunds will be issued if cancelled after 12th February 2024. \nPlease note the following registration conditions:\n\nRegistration to the course is only open for First Year Advanced Trainees in Adult Endocrinology \nTrainees must be undertaken the RACP Physicians Training Program in 2024\nIt is important to note that trainees are required to attend both days to receive their certificate of attendance\nEarly registration is recommended as places are strictly limited\nRegistration closes on Monday 22nd January 2024\n\nClick HERE to download the 2024 ADS Practical Skills Course Flyer  \nClick HERE to download the 2024 ADS Practical Skills Course Preliminary Program (Day 1; Saturday 17th February 2024) \n\n\nRegister Online\n\n \nFor any further details regarding the course\, please contact Ms Linda Valenzisi via email to linda@diabetessociety.com.au or visit the ADS website at Advanced Trainees (diabetessociety.com.au) \nThis course is financially supported under the National Diabetes Services Scheme (NDSS). The National Diabetes Services Scheme is an initiative of the Australian Government and is administered by Diabetes Australia. The ADS also gratefully acknowledges the contribution and support from Abbott Australia\, AMSL diabetes\, Insulet Australia\, Medtronic Diabetes Australia and Ypsomed Australia.
URL:https://www.diabetessociety.com.au/event/ads-practical-skills-course-2024/
LOCATION:Crowne Plaza Hotel Melbourne\, 1-5 Spencer St\, Melbourne\, VIC\, 3008\, Australia
CATEGORIES:ADS Education Courses for Advanced Trainees in Adult Endocrinology,ADS Educational Events,National Meetings,Virtual Event
ATTACH;FMTTYPE=image/jpeg:https://www.diabetessociety.com.au/wp-content/uploads/2023/11/PSC-flyer-2024-NEW-3-small.jpg
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20231123T190000
DTEND;TZID=Australia/Melbourne:20231123T200000
DTSTAMP:20260528T054015
CREATED:20231031T005941Z
LAST-MODIFIED:20231031T005941Z
UID:10000052-1700766000-1700769600@www.diabetessociety.com.au
SUMMARY:A New Standard of Care: The Role of SGLT2i in Type 2 Diabetes
DESCRIPTION:Join us on Thursday\, 23 November 2023 from 7:00 pm to 8:00 pm (AEDT) as we discuss the following in relation to the role of SGLT2 inhibitors in type 2 diabetes: \n\nThe benefits of SGLT2i on glycaemia\, CVD and CLD\nThe benefits of early glycaemic management of type 2 diabetes\nAddressing the barriers for SGLT2i use in type 2 diabetes\nThe ideal situation for SGLT2i initiation\n\nSpeakers\n \nClick here to view the event flyer.\nClick here to register for the webinar. \nThis webinar is registered for 1 CPD hour with the RACGP CPD Program and certificate of attendance available upon request. \nFor any further information please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\n    The ADS gratefully acknowledges the support from Boehringer Ingelheim and Lilly for this educational diabetes webinar.
URL:https://www.diabetessociety.com.au/event/a-new-standard-of-care-the-role-of-sglt2i-in-t2d/
CATEGORIES:ADS Educational Events,General,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2023/10/Banner_ADS-Webinar_23-Nov-2023.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20231113T190000
DTEND;TZID=Australia/Melbourne:20231113T200000
DTSTAMP:20260528T054015
CREATED:20231013T055004Z
LAST-MODIFIED:20231110T010609Z
UID:10000049-1699902000-1699905600@www.diabetessociety.com.au
SUMMARY:Management of Cardiovascular Disease in People with Obesity – Outcomes from the AHA Scientific Sessions 2023
DESCRIPTION:Live Panel Discussion\nJoin our panel of experts on Monday\, 13 November 2023 from 7:00 pm to 8:00 pm (AEDT) as they discuss the outcomes of the American Heart Association (AHA) Scientific Sessions 2023 in relation to the advancements in managing cardiovascular disease in people living with obesity. \nWe will be reviewing trial results presented at AHA and their implications for clinical practice in Australia. \nClick here to view the event flyer.\nClick here to register for the event. \nRegistration is free to attend. This webinar is registered for 1 CPD hour with the RACGP CPD Program. \nFor any further information please contact the ADS Secretariat via email to admin@diabetessociety.com.au \nSpeakers\n \n     \nThe ADS gratefully acknowledges the support from Novo Nordisk and Medi-Spec Solutions. This is an independent educational event and Novo Nordisk and Medi-Spec Solutions do not have an influence on the program\, speakers or presentations.
URL:https://www.diabetessociety.com.au/event/outcomes-from-the-aha-scientific-sessions-2023/
CATEGORIES:ADS Educational Events,General,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2023/10/Banner_ADS-Webinar_13-Nov-2023_v3.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20231028T080000
DTEND;TZID=Australia/Melbourne:20231029T130000
DTSTAMP:20260528T054015
CREATED:20230919T084417Z
LAST-MODIFIED:20231020T090621Z
UID:10000047-1698480000-1698584400@www.diabetessociety.com.au
SUMMARY:ADS Diabetes Technology Workshop 2023
DESCRIPTION:The Australian Diabetes Society is proud to host the ADS Diabetes Technology Workshop which will be held over 1.5 days on Saturday 28 & Sunday 29 October 2023 in Melbourne at the Crowne Plaza Hotel. \nThe workshop is primarily open to clinicians who consult and manage people living with type 1 diabetes. The aim of the workshop is to provide structured practical training about insulin pumps and other technologies used in diabetes self-management. This workshop contains new content to reflect the recent developments in insulin pump therapy and CGM technologies. The program will consist of a series of small group workshops\, with between 6-8 participants per group. This will allow for hands-on skills acquisition. Each workshop will be supported by structured written materials.  \nTopics to be covered include: \nFamiliarisation and understanding pump settings\, Continuous glucose monitoring\, Dietary management with AID systems\, Automated Insulin Delivery Systems\, Interpreting technology downloads\, Exercise and pumps\, New and emerging developments in insulin pump therapy.\n \n\nYou can download the 2023 ADS Diabetes Technology Workshop Flyer\nYou can download the 2023 ADS DT Workshop Preliminary Program_Day 1 and Day 2 (please check the program for timings AEDT on both days)\n\nOptional Pre-Workshop:\nThere will be an option for delegates to attend a pre-workshop on ‘Introduction to Diabetes Technology’ that will be held on Saturday 28 October from 8:00am to 9:00am. This pre-workshop is recommended for those clinicians who have minimal experience with diabetes technology especially in using insulin pumps. Spaces are very limited for the pre-workshop; you will need to advise during the registration process if you wish to attend. \nNetworking Dinner Function:\nThere will be a ‘Fast & Furious’ session held during the networking dinner function on Saturday 28 October from 5:30pm to 8:30pm with the supporting diabetes technology companies invited to present highlights of their products. \nRegistration Fees:\nRegistration fee includes attendance to both Day 1 and Day 2\, the optional pre-workshop\, networking dinner function on Saturday 28 October\, program handbook\, all workshop resources/handouts. \nADS Member Registration Fee is $198 (includes $18 GST) / Non-Member Registration Fee is $330 (includes $30 GST) \n  \nPlease note that registration is now fully booked for the ADS Diabetes Technology Workshop.  \n\n\nRegister Online\n\n \nPlease note the following conditions: \n\nEarly registration is recommended as places are strictly limited.\nDelegates travelling from interstate will need to organise their own travel arrangements (air travel and accommodation) to attend the workshop in Melbourne.\nIf you are not a member of the Australian Diabetes Society and wish to join; to apply for ADS Membership\, please go to the following link ADS Membership – Australian Diabetes Society via the ADS website to submit your Membership Application Form.\nCancellation fees do apply. Please provide the ADS Secretariat notice by no later than Monday 23 October 2023 if you are unable to attend the workshop. After this date\, the registration fee will be non-refundable.\n\nFor any further workshop details\, please contact Ms Linda Valenzisi via email to linda@diabetessociety.com.au\n \nRegistration closes on Wednesday 18 October 2023.\n \nThis workshop is financially supported under the National Diabetes Services Scheme (NDSS). The NDSS is an initiative of the Australian Government and is administered by Diabetes Australia. The Australian Diabetes Society gratefully acknowledges the generous support also provided from Abbott Australasia\, Australasian Medical & Scientific Ltd\, Insulet Australia\, Medtronic Australasia and Ypsomed Australia.
URL:https://www.diabetessociety.com.au/event/ads-diabetes-technology-workshop-2023/
LOCATION:Crowne Plaza Hotel Melbourne\, 1-5 Spencer St\, Melbourne\, VIC\, 3008\, Australia
CATEGORIES:ADS Educational Events
ATTACH;FMTTYPE=image/jpeg:https://www.diabetessociety.com.au/wp-content/uploads/2023/09/2023-ADS-Diabetes-Technology-Workshop-Flyer_Final-v2-small-scaled.jpg
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20230914T190000
DTEND;TZID=Australia/Melbourne:20230914T200000
DTSTAMP:20260528T054015
CREATED:20230829T022412Z
LAST-MODIFIED:20230829T024400Z
UID:10000045-1694718000-1694721600@www.diabetessociety.com.au
SUMMARY:Update on Heart Failure and Diabetes – Trials\, Guidelines and Treatments
DESCRIPTION:Join us on Thursday\, 14 September 2023 from 7:00 pm to 8:00 pm (AEST) as we discuss trials\, guidelines and treatments relating to heart failure and diabetes. \nDiscussion points include: \n\nDifferentiating reduced and preserved heart failure – are these patients truly different?\nLatest learnings from clinical trials\nCardiology guidelines in practice\nDiabetes guidelines – are we on the same page?\nGuidelines into clinical practice – a “one size fits all” or “individualised patient care”?\n\n\nSpeakers\n \nClick here to view the event flyer.\nClick here to register for the webinar. \nThis webinar is registered for 1 CPD hour with the RACGP CPD Program and certificate of attendance available upon request. \nFor any further information please contact the ADS Secretariat via email to admin@diabetessociety.com.au \n\n    \nThe ADS gratefully acknowledges the support from AstraZeneca and Medi-Spec Solutions for this educational diabetes webinar.
URL:https://www.diabetessociety.com.au/event/update-on-heart-failure-and-diabetes-trials-guidelines-treatments/
CATEGORIES:ADS Educational Events,General,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2023/08/ADS-Webinar-14-Sep-2023.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Adelaide:20230822T130000
DTEND;TZID=Australia/Adelaide:20230822T190000
DTSTAMP:20260528T054015
CREATED:20230324T070234Z
LAST-MODIFIED:20230731T020154Z
UID:10000028-1692709200-1692730800@www.diabetessociety.com.au
SUMMARY:ADS Early Career Network Workshop 2023
DESCRIPTION:We invite all early career ADS members to be part of the ADS Early Career Network (ECN)\, an ADS initiative to support clinicians and scientists with an interest in diabetes. The ECN Committee has developed a structure focused on four key pillars; research\, education\, professional development and social networking. By working collaboratively with senior ADS members\, we hope to build a community of peer-to-peer support and to help our early career members increase their visibility and maximise their skills and impact. The ECN Committee is excited to offer an exclusive half-day workshop to a limited number of ADS early career members attending #23ADC on Tuesday 22nd August\, 2023. This workshop\, which is designed and led by early career members with the support of senior facilitators will focus on our four key pillars and offer a unique opportunity to network and shape the future of the ECN. The Workshop will be held at the Adelaide Oval (Premiership Suite on Level 3) and you are required to attend the Australasian Diabetes Congress to register for the ADS ECN Workshop. Registration fee is $55 (includes $5 GST). For any further information please contact the ADS Secretariat via email to admin@diabetessociety.com.au \nClick to view the event flyer.\nClick to view the program.
URL:https://www.diabetessociety.com.au/event/ads-early-career-network-workshop-2023/
LOCATION:Adelaide Oval\, Adelaide\, SA\, Australia
CATEGORIES:ADS Educational Events,General,National Meetings
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2023/04/ADS-ECN-50-logo-2-e1680509402988.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20230720T190000
DTEND;TZID=Australia/Sydney:20230720T200000
DTSTAMP:20260528T054015
CREATED:20230706T054523Z
LAST-MODIFIED:20230706T063247Z
UID:10000042-1689879600-1689883200@www.diabetessociety.com.au
SUMMARY:Management of CKD in Diabetes: Putting Evidence into Practice
DESCRIPTION:The availability of SGLT2i has revolutionised the management of chronic kidney disease and diabetes.\nJoin us on Thursday\, 20 July 2023 from 7:00 pm to 8:00 pm (AEST) as we explore the latest evidence of how this class of drugs protects the kidney and the evidence for best practice when managing people with diabetes. \nDiscussion points include: \n\nWhy SGLT2i is the class of choice for protecting the kidney\nEarly use of SGLT2i in the management of type 2 diabetes\nThe ideal patient for starting SGLT2i\nSick day management plans and other areas of discussion\n\nSpeakers\n \nClick here to view the event flyer.\nClick here to register for the webinar. \nThis webinar is registered for 1 CPD hour with the RACGP CPD Program and certificate of attendance available upon request. \nFor any further information please contact the ADS Secretariat via email to admin@diabetessociety.com.au \n\nThe ADS gratefully acknowledges the support from AstraZeneca for this educational diabetes webinar.
URL:https://www.diabetessociety.com.au/event/management-of-ckd-in-diabetes-putting-evidence-into-practice/
CATEGORIES:ADS Educational Events,General,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2023/07/ADS-Webinar-20-July-2023.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20230518T190000
DTEND;TZID=Australia/Sydney:20230518T200000
DTSTAMP:20260528T054016
CREATED:20230508T092442Z
LAST-MODIFIED:20230510T051806Z
UID:10000041-1684436400-1684440000@www.diabetessociety.com.au
SUMMARY:The Future of CKD Management in Diabetes – What We Have Learnt from the Trials to Date
DESCRIPTION:Join us on Thursday\, 18 May 2023 from 7:00 pm to 8:00 pm (AEST) as we discuss what we have learnt from CKD studies in the last 12 months and how this knowledge is changing diabetes management. \nDiscussion points include: \n\nThe ideal patient for SGLT2i\nHow low can you go with respect to SGLT2i\nFinerenone\, GLP-1a and their role in CKD\nLifestyle measures\n\nThis is an important discussion for all health professionals treating people with CKD and with and without diabetes. \nSpeakers\n \nClick here to view the event flyer.\nClick here to register for the webinar. \nThis webinar is registered for 1 CPD hour with the RACGP CPD Program and certificate of attendance available upon request. \nFor any further information please contact the ADS Secretariat via email to admin@diabetessociety.com.au \n\n    The ADS gratefully acknowledges the support from Boehringer Ingelheim and Lilly for this educational diabetes webinar.
URL:https://www.diabetessociety.com.au/event/the-future-of-ckd-management-in-diabetes-what-we-have-learnt-from-the-trials-to-date/
CATEGORIES:ADS Educational Events,General,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2023/05/ADS-Webinar-18-May-2023.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20230511T000000
DTEND;TZID=Australia/Melbourne:20230512T235959
DTSTAMP:20260528T054016
CREATED:20230315T064506Z
LAST-MODIFIED:20230504T002553Z
UID:10000026-1683763200-1683935999@www.diabetessociety.com.au
SUMMARY:Australian Islet Study Group Meeting 2023
DESCRIPTION:The Australian Islet Study Group (AISG) Meeting is the premier meeting for researchers interested in all aspects of islet and beta cell function; including secretion pathway mechanisms\, islet structure and function\, morphology\, in vitro and in vivo models\, omics and big data considerations. We invite you to attend this exciting annual meeting discussing islet biology as it relates to clinical situations including diabetes and challenges in islet transplantation. The AISG Meeting 2023 will take place on Thursday\, 11th & Friday\, 12th May 2023 at the Charles Perkins Centre in Sydney (within the Camperdown campus of the University of Sydney).\n\nClick here for the preliminary program.\nClick here to register for the event.\n\nStudent registration: A$80.00 (GST included)\nFull registration: A$180.00 (GST included)\n\n\n\n\n\nSpeakers\n\n\n\n\n\n\n\n\n\n\n\n\nKeynote Speaker\nAssistant Professor Samuel Stephens\nSamuel Stephens is an Assistant Professor of Medicine and member of the Fraternal Order of Eagles Diabetes Research Center at the University of Iowa in USA. He has expertise in secretory protein biogenesis and trafficking\, ER stress response\, hormone secretion\, metabolism\, and pancreatic islet cell function. Assistant Professor Stephens’ laboratory focuses on understanding the molecular mechanisms that coordinate nutrient metabolism with ß-cell secretory capacity and how dysregulation of these pathways contributes to the loss of ß-cell function in major forms of diabetes.\n\n\n\n\n\n\n\n\n\n\n\n\n\nProgram\n\n\nClick to view the preliminary program.\n\n   The ADS gratefully acknowledges the support from Lilly and Novo Nordisk for this educational event.
URL:https://www.diabetessociety.com.au/event/australian-islet-study-group-meeting-2023/
LOCATION:Charles Perkins Centre at the University of Sydney\, John Hopkins Drive\,\, Camperdown\, NSW\, 2050\, Australia
CATEGORIES:ADS Educational Events,General,National Meetings
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2023/03/AISG-2023-image-website.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20230419T190000
DTEND;TZID=Australia/Sydney:20230419T203000
DTSTAMP:20260528T054016
CREATED:20230403T070245Z
LAST-MODIFIED:20230411T091913Z
UID:10000039-1681930800-1681936200@www.diabetessociety.com.au
SUMMARY:Making the Most of the #23ADC
DESCRIPTION:The ADS is proud to launch the Early Career Network (ECN) with an online meeting featuring ADS members from various stages in their careers discussing tips and advice for Making the Most of #23ADC. \nJoin us on Wednesday 19th April 2023 from 7.00pm to 8.30pm (AEST) to discuss the following topics in relation to the 2023 Australasian Diabetes Congress (ADC): \n\nThe one thing that will differentiate your abstract from the others\nCongratulations! You have a poster presentation – what’s next?\nMaking the most of an oral presentation – simple and informative\nWhy asking a question in a session is important\nHow to effectively network with your peers and leaders in your field\n\nClick here to view the webinar event flyer \nClick here to register for the webinar event \nFor any further information please contact the ADS Secretariat via email to admin@diabetessociety.com.au
URL:https://www.diabetessociety.com.au/event/making-the-most-of-the-23adc/2023-04-19/
CATEGORIES:ADS Educational Events,National Meetings,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2023/04/ADS-ECN-50-logo-2-e1680509402988.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
END:VCALENDAR